Risk Management: Patient Safety; Public Safety and OTP Liability

Risk Management:Patient Safety; Public Safety

and OTP Liability

Lisa Torres, JD

2

Objectives of this webinar:Objectives of this webinar:

• Provide a foundation for risk management as an Provide a foundation for risk management as an ongoing processongoing process in OTP’s in OTP’s

• Focus on current patient and public safety concerns Focus on current patient and public safety concerns associated with induction, impairment; and take-home associated with induction, impairment; and take-home medicationmedication

• Address developments in OTP liability including Address developments in OTP liability including liability for third party injury and deathliability for third party injury and death

• Offer strategies to help control safety and liability risks Offer strategies to help control safety and liability risks in OTP’sin OTP’s

3

Omissions from this webinar:Omissions from this webinar:

• Not lecturing on law or practice guidelines but using Not lecturing on law or practice guidelines but using actual claims to identify trends and prepare responses actual claims to identify trends and prepare responses

• Not giving legal advice specific to each OTP’sNot giving legal advice specific to each OTP’s• Not implying that application of these strategies or Not implying that application of these strategies or

even adoption of best clinical practices will insulate even adoption of best clinical practices will insulate OTP’s from being the subject of legal actions. OTP’s from being the subject of legal actions.

This webinar hopes to:

• Use authentic sources to identify trends and work through actual claims to illustrate clinical and legal standards

• Engage everyone by limiting seminar’s scope to a few current issues of concern to the OTP field: induction dosing; impairment & take-home

• Use a hands-on approach in sharing creative, practical, actually used and cost-effective risk treatment strategies, tips and resources to inspire OTP’s to borrow those of potential value to them

4

5

Risk Management ExplainedRisk Management Explained

• Ideally, a processIdeally, a process of identifying loss exposures faced of identifying loss exposures faced by an organization & creating most appropriate by an organization & creating most appropriate response/s response/s

• Often Risk Management confused with Risk Often Risk Management confused with Risk Assessment, but need additional separate processes Assessment, but need additional separate processes that link together to integrate a continuous culture of that link together to integrate a continuous culture of risk management into an organizationrisk management into an organization

• Heart of RM: risk assessment: identification, analysis and evaluation of risks and risk treatment

6

Risk Management CycleRisk Management Cycle

Risk Assessment:Identify risk(s)

AnalyzeEvaluate

Risk TreatmentIdentify options

Develop Plan of ActionApprove & Implement

CommunicationThroughout OTPRisk AwarenessMonitoring &

Ongoing Review

Define Scope and Frameworrk for

OTP’s Risk ManagementStrategy

7

Risk Assessment*Risk Assessment*

• Identification risks (loss exposure) – use OTP resources, Identification risks (loss exposure) – use OTP resources, i.e., incident reports; audits, patient complaints, i.e., incident reports; audits, patient complaints, accreditation response & state monitors, news from the accreditation response & state monitors, news from the field, etc.field, etc.

• Analysis – of loss exposure (potential loss) in terms of Analysis – of loss exposure (potential loss) in terms of frequency, likelihood & severity (of impact), frequency, likelihood & severity (of impact),

• Evaluation of options - prioritize risk in terms of costs in Evaluation of options - prioritize risk in terms of costs in time, money, resources, goodwill, etc.time, money, resources, goodwill, etc.

• **Not the same as risk managementNot the same as risk management

Risk Control/Treatment OptionsRisk Control/Treatment Options• Identify risk response options that give “the most bang

for the buck” through: – Prevention (reduce likelihood) e.g., to reduce patient safety

complications related to induction, to assure individualized care, OTP implements new policy to discontinue use of physician’s standing orders during induction, until patient has achieved optimal dose stabilization; Narcan in OTP, etc.

– Reduction of severity (contain loss after an adverse event occurs) e.g. Adopt plan to respond to families after injury/death (e.g., Sorry Works)

– Loss control (reduce frequency of loss) e.g., to minimize patients from leaving treatment prematurely, conduct focus group and identify related factors. To the extent high fees are a major factor, change policies offering reduced rates to patients who require reduced services and offer incentives to encourage these patients to remain in treatment.

8

Risk Control/Treatment Options, cont.

– Acceptance (do nothing; accept risk) e.g., risk of cardiac arrythmia in long term, stabilized patients too remote to warrant action

– Avoidance (withdraw from activity that is the source of the risk); e.g., no longer accepting patients who use benzodiazapine

– Transfer (share with other/entities who have with better resources or options) e.g., refer patients with co-occurring mental health issues to psychiatric providers

– Loss control (reduce frequency of loss) e.g., to minimize patients from leaving treatment prematurely, conduct focus group and identify related factors. To the extent high fees are a major factor, change policies offering reduced rates to patients who require reduced services and offer incentives to encourage these patients to remain in treatment.

9

10

OTP Ideal Standard of Care*OTP Ideal Standard of Care*

• From admission, each patient receives:From admission, each patient receives:ongoing, documented, individualized clinical care by ongoing, documented, individualized clinical care by competent staff acting within their appropriate scope competent staff acting within their appropriate scope of practice, using good clinical judgment in of practice, using good clinical judgment in accordance with OTP clinical practice standards and accordance with OTP clinical practice standards and incorporating best evidence-based practices. incorporating best evidence-based practices.

* * Borrowed from CSAT Workshop on Risk Management - 2005Borrowed from CSAT Workshop on Risk Management - 2005

11

Establishing Dependence, Establishing Dependence, WithdrawalWithdrawal& Tolerance to Opioids& Tolerance to Opioids• Legally (42 C.F.R. Section 8, (12) et.seq.) must be “opioid Legally (42 C.F.R. Section 8, (12) et.seq.) must be “opioid

dependent” or meet exceptiondependent” or meet exception• Not an opioid addict because patient says so …Not an opioid addict because patient says so …• ““Street script” - buzz words/acts to receive methadoneStreet script” - buzz words/acts to receive methadone• Ask patient whether taken methadone before and to describe , Ask patient whether taken methadone before and to describe ,

“withdrawal” symptoms as experienced“withdrawal” symptoms as experienced• Need to observe objective signs of withdrawal as only evidence of Need to observe objective signs of withdrawal as only evidence of

dependence (Refer to C.O.W. Scale)dependence (Refer to C.O.W. Scale)• Tolerance can’t be measured; it is estimated based largely on Tolerance can’t be measured; it is estimated based largely on

patient’s self-disclosure and proof of withdrawal.patient’s self-disclosure and proof of withdrawal.

12

Added Risks at AdmissionAdded Risks at Admission

• Don’t know patient; what other substances may be on board; not Don’t know patient; what other substances may be on board; not certain of patient’s certain of patient’s tolerancetolerance level level

• Patients’ responses to methadone vary considerably given Patients’ responses to methadone vary considerably given different metabolism; rates of absorption, digestion and excretion different metabolism; rates of absorption, digestion and excretion which in turn are influenced by body weight and size, other which in turn are influenced by body weight and size, other substance use, diet, co-occurring disorders, medical diseases substance use, diet, co-occurring disorders, medical diseases and genetic factors.and genetic factors.

• Methadone remains in body tissues longer than its peak effect Methadone remains in body tissues longer than its peak effect disguising potentially toxic build up, especially when tolerance disguising potentially toxic build up, especially when tolerance hasn’t been built up.hasn’t been built up.

13

Balancing ActBalancing Act

• Docs treating for opioid addiction must balance risks Docs treating for opioid addiction must balance risks of under-medicating (patient will not be relieved of of under-medicating (patient will not be relieved of withdrawal) and over-medicating (patient will be withdrawal) and over-medicating (patient will be sedated, impaired)sedated, impaired)

• Risk of under-medicating is that patient will resort to Risk of under-medicating is that patient will resort to illicit substances, self-medication to seek reliefillicit substances, self-medication to seek relief

• Risk of over-medicating is overdose, or patient Risk of over-medicating is overdose, or patient impairment to the extent driving becomes dangerous impairment to the extent driving becomes dangerous and a foreseeable risk of safety to others. and a foreseeable risk of safety to others.

14

RM Strategies to Maximize RM Strategies to Maximize Medication Safety at InductionMedication Safety at Induction• High variation between patients and unverifiable High variation between patients and unverifiable

information warrants:information warrants:• 1. Highly individualized care in dosing, etc.1. Highly individualized care in dosing, etc.• 2. Enhanced monitoring for first five days or until 2. Enhanced monitoring for first five days or until

stabilization (all OTP staff monitor for signs of: stabilization (all OTP staff monitor for signs of: withdrawal vs. overmedication, impairment)withdrawal vs. overmedication, impairment)

• 3. Improve language and communication to inform 3. Improve language and communication to inform and educate new patients about severity ofand educate new patients about severity of

RM Strategies to Maximize RM Strategies to Maximize Medication Safety at Induction, Medication Safety at Induction, cont.cont.• Include and engage patient in minimizing risks Include and engage patient in minimizing risks

associated with induction dosing via Educationassociated with induction dosing via Education• Include “Strategies for Reducing Overdose Deaths” – Include “Strategies for Reducing Overdose Deaths” –

a list of vital information to educate patients and a list of vital information to educate patients and relatives or friends and the chart, “What to Watch For relatives or friends and the chart, “What to Watch For – Signs/Symptoms of Overmedication/Overdose” from – Signs/Symptoms of Overmedication/Overdose” from Addiction Treatment Forum, Vol. 16, #3, Summer Addiction Treatment Forum, Vol. 16, #3, Summer 2000720007

15

16

OTP Core Liability RisksOTP Core Liability Risks

• Failure to document patient’s receipt of “individualized care”Failure to document patient’s receipt of “individualized care”• Failure to review OTP policy/ies, procedure/s and practices to determine Failure to review OTP policy/ies, procedure/s and practices to determine

whether they are effective in protecting patients’ safety and protecting whether they are effective in protecting patients’ safety and protecting against foreseeable harm to others ORagainst foreseeable harm to others OR

• Failure to correct policies, procedures and practices that are ineffectiveFailure to correct policies, procedures and practices that are ineffective• Ignoring “red flags” – incidents that are outside realm of “usual and Ignoring “red flags” – incidents that are outside realm of “usual and

customary” customary” • Failing to consider what’s “reasonable” and “foreseeable ? LOGIC Failing to consider what’s “reasonable” and “foreseeable ? LOGIC

MODELMODEL• Failure to communicate to patients the risks regarding true and full Failure to communicate to patients the risks regarding true and full

disclosure of their use of other substances including prescribed disclosure of their use of other substances including prescribed medications, medical histories, other medical providers,conditions, etc. medications, medical histories, other medical providers,conditions, etc.

17

Malpractice ElementsMalpractice Elements• A duty owed – legal duty of health care provider to A duty owed – legal duty of health care provider to

provide care and treatment of a patient;provide care and treatment of a patient;• A duty breached – the provider did not meet the A duty breached – the provider did not meet the

““relevant standard of care”*relevant standard of care”*• The breach was the proximate cause of the injury;The breach was the proximate cause of the injury;• Damages in the sense of pecuniary or emotional (no Damages in the sense of pecuniary or emotional (no

injury, no claim). injury, no claim). • * * Established and supported by various sources such as Established and supported by various sources such as

SAMHSA/CSAT Treatment Improvement Protocols (43), Clinical SAMHSA/CSAT Treatment Improvement Protocols (43), Clinical Practice Guidelines, peer reviewed research and professional specialty Practice Guidelines, peer reviewed research and professional specialty publications, etc.publications, etc.

18

LEGAL STANDARDSLEGAL STANDARDS

• Established in fed regulations (42 C.F.R. Section 8.12 Established in fed regulations (42 C.F.R. Section 8.12 et.seq.), state, local statutes/regulations and case lawet.seq.), state, local statutes/regulations and case law

• Compliance with legal standards is critical but will not Compliance with legal standards is critical but will not insulate an OTP from liability; and it only evidence of insulate an OTP from liability; and it only evidence of having met legal standard/s, not of having met the having met legal standard/s, not of having met the clinical standard /s of care and duty owed to patients, clinical standard /s of care and duty owed to patients, etc.etc.

• However non-compliance is strong evidence of not However non-compliance is strong evidence of not having met legal or medical standards of care.having met legal or medical standards of care.

19

Strategies: Controlling Strategies: Controlling Induction RisksInduction Risks• HEIGHTENED PATIENT MONITORING THROUGH HEIGHTENED PATIENT MONITORING THROUGH

STABILIZATION: Given many “unknown” factors of new patients STABILIZATION: Given many “unknown” factors of new patients at induction, in light of the increased likelihood of harm; at induction, in light of the increased likelihood of harm;

• Integrate patient and his/her family into the safety netIntegrate patient and his/her family into the safety net• Encourage patients to engage family members from the beginning Encourage patients to engage family members from the beginning

and, whenever possible to give OTP permission to discuss over-and, whenever possible to give OTP permission to discuss over-medication, etc. with a designated person;medication, etc. with a designated person;

• Have family members know to call OTP with questions ; Have family members know to call OTP with questions ; • Identify and remove dis-incentives for patients and their families to Identify and remove dis-incentives for patients and their families to

fully disclose poly-substance use, misuse, abuse (rewarding or fully disclose poly-substance use, misuse, abuse (rewarding or encouraging honesty) encouraging honesty)

Strategies: Controlling Strategies: Controlling Induction Risks, continuedInduction Risks, continued• Identify and remove dis-incentives for patients (and

their families) to fully disclose poly-substance use, misuse, abuse (rewarding or encouraging honesty)

• Align everyone, including all OTP staff to be diligent about identifying all potential danger signs & symptoms (i.e., red flags, etc.) of methadone and taking appropriate action thereon.

20

Elements of Informed Consent: In Methadone Maintenance Treatment • A patient’s written informed consent to [voluntary]

treatment is the OTP’s program physicians’ responsibility under 42 C.F.R. Section 8.12(e)(i).

• Patients’ consent represents competency to understand and appreciate what methadone is; what it’s supposed to do; how it does this; side effects and options.

• Communication must include all material risks that could potentially affect the patient’s decision; enough information for the patient to be able to appreciate the risks of harm vs. benefits as they change.

• Consent must be “voluntary”; can’t be given while under pressure/threat of coersion/duress (consider opioid addicts’ state in early days of withdrawal and induction) 21

22

Informed ConsentInformed Consent

• A patient’s signature on an informed consent form is A patient’s signature on an informed consent form is evidenceevidence that informed consent was obtained, that informed consent was obtained, however, it is however, it is not a substitute for the informed not a substitute for the informed consent processconsent process. Consider duress of being in opioid . Consider duress of being in opioid withdrawal; coercive nature of having to sign a withdrawal; coercive nature of having to sign a consent form consent form priorprior to being “dosed”, etc. to being “dosed”, etc.

• Patient consent is ongoing: would a reasonable Patient consent is ongoing: would a reasonable person wish to alter treatment decisions based upon person wish to alter treatment decisions based upon more or different information; if so re-new consent. more or different information; if so re-new consent.

23

Elements of Informed Consent in Elements of Informed Consent in Opioid TreatmentOpioid Treatment

• Nature and purpose of methadoneNature and purpose of methadone• Benefits, risks and side effects of methadoneBenefits, risks and side effects of methadone• AlternativesAlternatives to methadone, (safer, with less side effects; to methadone, (safer, with less side effects;

etc., ie., Suboxone, Naltrexone etc.) including option of etc., ie., Suboxone, Naltrexone etc.) including option of no medication/treatmentno medication/treatment

• Informing patients of restrictions, patients’ responsibilities, Informing patients of restrictions, patients’ responsibilities, policies and procedures and potential impact upon policies and procedures and potential impact upon treatment, expecially consequences of fee arrears. treatment, expecially consequences of fee arrears.

24

PharmacoviligencePharmacoviligence

• Pharmacological science relating to detection, Pharmacological science relating to detection, assessment, understanding and prevention of adverse assessment, understanding and prevention of adverse effects, including long and short term side effects of effects, including long and short term side effects of medicines. medicines.

• Used as a clinical standard potentially defining duty to Used as a clinical standard potentially defining duty to verify patients’ use of prescribed drugs and to identify verify patients’ use of prescribed drugs and to identify (and possibly prevent) dangerous drug-to-drug (and possibly prevent) dangerous drug-to-drug interactions or otherwise cause a patient to become interactions or otherwise cause a patient to become impaired and give rise to foreseeable third parties.impaired and give rise to foreseeable third parties.

• Instruments: use of internet technology to obtain drug-Instruments: use of internet technology to obtain drug-to-drug interactionsto-drug interactions

25

Multiple Sources of ImpairmentMultiple Sources of Impairment

• Initial induction dosing; over-medicating, prior to Initial induction dosing; over-medicating, prior to stabilization;stabilization;

• Drug-to-drug interactions can cause impairment, i.e., Drug-to-drug interactions can cause impairment, i.e., benzo’s, etc. benzo’s, etc.

• Some medical conditions, ie. epilepsy, etc. can Some medical conditions, ie. epilepsy, etc. can threaten to cause or result in a patient’s impairment;threaten to cause or result in a patient’s impairment;

• Patients use of other substances, ie. alcohol, etc.Patients use of other substances, ie. alcohol, etc.

26

OTP Know or Should Know…OTP Know or Should Know…• Case law is extending liability to OTP’s for harm Case law is extending liability to OTP’s for harm

caused by a patient’s impaired driving when the OTP caused by a patient’s impaired driving when the OTP “knew or should have known” patient would drive “knew or should have known” patient would drive while impaired and harm to others was foreseeable. while impaired and harm to others was foreseeable. OTP’s charged with knowledge when evidence was OTP’s charged with knowledge when evidence was ignored (ie., recent urine screens, reports of patient ignored (ie., recent urine screens, reports of patient stumbling or unable to keep eyes open on medication stumbling or unable to keep eyes open on medication line); Duty to other non-patients born out of case law line); Duty to other non-patients born out of case law Tarasoff;Tarasoff; no interception attempted; breach of duty no interception attempted; breach of duty OTP’s can’t afford to “bury heads in the sand” – OTP’s can’t afford to “bury heads in the sand” – should ask patients about transportation to OTP and should ask patients about transportation to OTP and whether alternatives means are available, etc.whether alternatives means are available, etc.

27

ImpairmentImpairment

• Strategies to identify and screen for use and abuse of other Strategies to identify and screen for use and abuse of other substances that cause impairment and would place certain substances that cause impairment and would place certain patients at higher risk (urine screens; prescription monitoring, patients at higher risk (urine screens; prescription monitoring, closer observations, etc.)closer observations, etc.)

• Strategies/tools to help identify patients who drive long Strategies/tools to help identify patients who drive long distances to the OTP; distances to the OTP;

• OTP has duty warn patients of risks of driving while impaired OTP has duty warn patients of risks of driving while impaired and to disclose its duty to report to Motor Vehicles suspected and to disclose its duty to report to Motor Vehicles suspected and potential impaired drivers (see each state’s law)and potential impaired drivers (see each state’s law)

28

Duty to Report/Prescription Duty to Report/Prescription MonitoringMonitoring• Several states impose a legal duty to report “suspected” Several states impose a legal duty to report “suspected”

impaired drivers to the Dept. of Motor Vehicle; impaired drivers to the Dept. of Motor Vehicle; • Prescription monitoring is an internet based data bank of Prescription monitoring is an internet based data bank of

all prescriptions written within a state’s boundaries. all prescriptions written within a state’s boundaries. With a password, OTP’s can access these data banks to With a password, OTP’s can access these data banks to verify whether and which medications patients are verify whether and which medications patients are prescribed in order to identify potential drug-to-drug prescribed in order to identify potential drug-to-drug interactions interactions

Legal Standard: Impaired DriversTo the extent an impaired or suspected impaired patient conduct can be influenced by an OTP’s intervention, OTP’s should have a policy, procedure and practice in place to do so.• If the medical staff

suspects you to be impaired so as to impose safety risk to yourself or others, you will not be medicated and will contact your safe designated driver or partner to escort you safely home until such time as you appear unimpaired.

• If you deny having or being impairment, you may request confirmation via immediate field sobriety testing or drug screening tests, however if actual impairment cannot be immediately confirmed, and you insist on driving or otherwise operating a heavy vehicle/ machinery in such a way that you are placing yourself or others in a state of potential harm, the OTP will first warn and then fulfill its legal obligation to report to the department of Motor Vehicles for their determination.

29

30

Third PartiesThird Parties

• Tarasoff’Tarasoff’s duty to warn strangers, third parties who s duty to warn strangers, third parties who are are prospective victims and imposed a dprospective victims and imposed a duty to uty to protect others from protect others from foreseeable risks of harm/injuryforeseeable risks of harm/injury

• Potential harm to pedestrians and other drivers that is Potential harm to pedestrians and other drivers that is foreseeable (and too potentially severe to ignore); foreseeable (and too potentially severe to ignore);

Third parties can sue for injuries caused by the Third parties can sue for injuries caused by the actions of OTP patients.actions of OTP patients.

•

31

Take Home Medications - LawTake Home Medications - Law

• Federal Regulations permit OTP’s to circumvent usual Federal Regulations permit OTP’s to circumvent usual take-home criteria (rather stringent) for all patients on take-home criteria (rather stringent) for all patients on Sundays and holidays when the OTP is closed.Sundays and holidays when the OTP is closed.

• However, this regulation does not absolve OTP’s of However, this regulation does not absolve OTP’s of their standard of care and duties to patients and their standard of care and duties to patients and foreseeable third parties. foreseeable third parties.

• Still have duty to make sure all patients handle Still have duty to make sure all patients handle medication responsibly and meet other criteria.medication responsibly and meet other criteria.

32

Comparative vs. Contributory Comparative vs. Contributory NegligenceNegligence• Contributory negligence – a defense in negligence suits wherein Contributory negligence – a defense in negligence suits wherein

the plaintiff was barred from bringing suit if negligent at all;the plaintiff was barred from bringing suit if negligent at all;• Most states mandate that plaintiff cannot be half (50%+) or more Most states mandate that plaintiff cannot be half (50%+) or more

than half responsible (51%+) to file a complaint (modified than half responsible (51%+) to file a complaint (modified comparative fault system), but can otherwise have liability comparative fault system), but can otherwise have liability apportioned out among and between plaintiff and defendants, apportioned out among and between plaintiff and defendants,

• Several states today have “pure comparative negligence” case Several states today have “pure comparative negligence” case law and/or statutes that allow plaintiffs to bring negligence suits law and/or statutes that allow plaintiffs to bring negligence suits but then to apportion liability according to relative fault..but then to apportion liability according to relative fault..

33

INDUCTION TOOLKITINDUCTION TOOLKIT

• Initiate additional admission criteria (or conditions of admission) that inform patients prior to admission about patients’ responsibilities in partnering to help control risks associated with induction dosing, impairment (due to poly drug misuse) and take-home medications;

• Explore use of Narcan for overdose reversals; • Include use of phone calls to monitor new patients Include use of phone calls to monitor new patients

throughout the daythroughout the day

INDUCTION TOOLKIT, cont.INDUCTION TOOLKIT, cont.

• Restrict new admissions to Mondays – Thursdays, early enough to allow for 4-5 hour induction dose observations.

• Institute home phone call monitoring to all new patients for first five days minimum;

• Distribute, read, discuss and review pamplet, “Follow Directions: How to Use Methadone Safely”, U.S. Dept. Health & Human Services/SAMHSA publication (Appendix)

34

INDUCTION TOOLKIT, cont.INDUCTION TOOLKIT, cont.• Make sure patients and their housemates know to respond

immediately when palpitations, dizziness, lightheadedness or fainting. NEVER LET HIM/HER “SLEEP IT OFF”. Distribute to patients’ and families “Addiction Treatment Forum” Vol 16, #3, Summer 2007, Strategies for Reducing Overdose Deaths and What to Watch for – Signs & Symptoms of Overmedication/Overdose (Appendix)

• REFER to “Addiction Treatment Forum” Methadone-Drug Interactions, (3rd/2005 [4th] Edition) for thorough resource for methadone and medications, illicit drugs & other substances (Appendix)

• Clinical Suggestions for Minimizing Methadone-Drug Interactions• Drug Interaction Resources on the Internet - atforum.com

35

INDUCTION TOOLKIT, cont.INDUCTION TOOLKIT, cont.

• Consider “time management” training specially tailored for OTP physicians, medical directors and other healthcare professionals for time saving strategies to assure adequate chart documentation to substantiate individual patient care.

• Distribute and review Dr. J.T.Payte’s “Methadone Induction Guide” (Appendix)

• Incorporate patients’ family members, significant others in education, participation in preventing safety risks, etc.

36

TOOLKIT: IMPAIRMENT/DRIVING

Initiate new questionnaire that records the mode, route and total miles of transportation to and from the OTP each day, and work, where applicable for each patient.

• Include whether public transportation would be a possible option in an emergency and the names and phone numbers of two persons who could be counted on as “designated driver” in case alternative means were needed

37

38

IMPAIRMENT TOOLKIT, cont.IMPAIRMENT TOOLKIT, cont.

• Explore use of standardized field sobriety tests and drug impaired driving assessments

• Proactive planning to develop policies and procedures for intervening when impairment is suspected (see above)

Consent as a Risk Transfer Option• A tool to “transfer” some of the risk back onto the

patient who, after all, retains control of behavioral risk(s) (Check with State laws/regs.)

• Patient agrees to refrain from driving automobile if the OTP determines probable impairment to a point where unsafe to drive and to avoid a foreseeable risk of harm to driver and members of the public, driver surrenders keys for safe transportation alternative.

39

40

TAKE-HOME TOOLKITTAKE-HOME TOOLKIT

• Monitor patients’ take-home medications by imposing Monitor patients’ take-home medications by imposing a “bottle re-call or call back” procedure where patients a “bottle re-call or call back” procedure where patients are randomly asked to come in with their medication;are randomly asked to come in with their medication;

• Conduct random home safety inspectionsConduct random home safety inspections• Use of lock or storage boxes – make patients pick-up Use of lock or storage boxes – make patients pick-up

medications in the boxes (although risk of making medications in the boxes (although risk of making patients targets of those who would steal or purchase)patients targets of those who would steal or purchase)

• Random checks to make sure lock boxes functionRandom checks to make sure lock boxes function

41

Screening for Sources of Third Screening for Sources of Third Party Take-Home TipsParty Take-Home Tips

– Screen patients who have children in their home; Screen patients who have children in their home; increased diligence about protecting them from harm; increased diligence about protecting them from harm; assuring safe use of medication.assuring safe use of medication.

– Do not drink medicine in front of children; they tend to Do not drink medicine in front of children; they tend to mimic older peoplemimic older people

– Screen for patients who are using/abusing substances Screen for patients who are using/abusing substances and are more vulnerable /higher risk to sell medication; and are more vulnerable /higher risk to sell medication; (have been cases where patients who sold medication (have been cases where patients who sold medication were charged criminally)were charged criminally)